MORELLI, CRISTINA
MORELLI, CRISTINA
Development and validation of an inflammatory prognostic index to predict outcomes in advanced/metastatic urothelial cancer patients receiving immune checkpoint inhibitors
2024-01-01 Mokbel, S; Baciarello, G; Lavaud, P; Omlin, A; Calabro', F; Cathomas, R; Aeppli, S; Pauline, P; Giannatempo, P; Koster, K; Appel, N; Gonnet, P; Angius, G; Tsantoulis, P; Arkenau, H; Cattrini, C; Messina, C; Zeghondy, J; Morelli, C; Loriot, Y; Formica, V; Patrikidou, A
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?
2024-01-01 Riondino, S; Rosenfeld, R; Formica, V; Morelli, C; Parisi, G; Torino, F; Mariotti, S; Roselli, M
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling
2023-08-01 Formica, V; Riondino, S; Morelli, C; Guerriero, S; D'Amore, F; Di Grazia, A; Del Vecchio Blanco, G; Sica, G; Arkenau, H; Monteleone, G; Roselli, M
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis
2023-06-05 Formica, V; Morelli, C; Conca, V; Calegari, Ma; Lucchetti, J; Dell'Aquila, E; Schirripa, M; Messina, M; Salvatore, L; Lo Prinzi, F; Dima, G; Trovato, G; Riondino, S; Roselli, M; Skoulidis, F; Arkenau, H; Cremolini, C
Mucinous and Signet-Ring Cell Colonic Adenocarcinoma in Inflammatory Bowel Disease: A Case-Control Study
2023-07-26 Neri, B; Mancone, R; Savino, L; Schiavone, S; Formica, V; Pizzi, F; Salvatori, S; Mossa, M; Migliozzi, S; Fiorillo, M; Morelli, C; Moscardelli, A; Lolli, E; Calabrese, E; Sica, G; Monteleone, G; Biancone, L
Obesity and common pathways of cancer and cardiovascular disease
2020-01-01 Formica, V; Morelli, C; Riondino, S; Renzi, N; Nitti, D; Di Daniele, N; Roselli, M; Tesauro, M
PD-L1 thresholds predict efficacy of immune checkpoint inhibition in first-line treatment of advanced gastroesophageal adenocarcinoma. A systematic review and meta-analysis of seven phase III randomized trials
2024-11-01 Formica, V; Morelli, C; Fornaro, L; Riondino, S; Rofei, M; Fontana, E; Smyth, Ec; Roselli, M; Arkenau, H
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
2023-09-25 Morelli, C; Formica, V; Bossi, P; Rofei, M; Guerriero, S; Riondino, S; Argirò, R; Pucci, N; Cenci, T; Savino, L; Rinaldi, Cg; Garaci, F; Orlandi, A; D'Angelillo, Rm; Arkenau, H; Roselli, M
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2024 | Development and validation of an inflammatory prognostic index to predict outcomes in advanced/metastatic urothelial cancer patients receiving immune checkpoint inhibitors | Mokbel, S; Baciarello, G; Lavaud, P; Omlin, A; Calabro', F; Cathomas, R; Aeppli, S; Pauline, P; Giannatempo, P; Koster, K; Appel, N; Gonnet, P; Angius, G; Tsantoulis, P; Arkenau, H; Cattrini, C; Messina, C; Zeghondy, J; Morelli, C; Loriot, Y; Formica, V; Patrikidou, A | Articolo su rivista | |
| 1-gen-2024 | Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? | Riondino, S; Rosenfeld, R; Formica, V; Morelli, C; Parisi, G; Torino, F; Mariotti, S; Roselli, M | Articolo su rivista | |
| 1-ago-2023 | HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling | Formica, V; Riondino, S; Morelli, C; Guerriero, S; D'Amore, F; Di Grazia, A; Del Vecchio Blanco, G; Sica, G; Arkenau, H; Monteleone, G; Roselli, M | Articolo su rivista | |
| 5-giu-2023 | Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis | Formica, V; Morelli, C; Conca, V; Calegari, Ma; Lucchetti, J; Dell'Aquila, E; Schirripa, M; Messina, M; Salvatore, L; Lo Prinzi, F; Dima, G; Trovato, G; Riondino, S; Roselli, M; Skoulidis, F; Arkenau, H; Cremolini, C | Articolo su rivista | |
| 26-lug-2023 | Mucinous and Signet-Ring Cell Colonic Adenocarcinoma in Inflammatory Bowel Disease: A Case-Control Study | Neri, B; Mancone, R; Savino, L; Schiavone, S; Formica, V; Pizzi, F; Salvatori, S; Mossa, M; Migliozzi, S; Fiorillo, M; Morelli, C; Moscardelli, A; Lolli, E; Calabrese, E; Sica, G; Monteleone, G; Biancone, L | Articolo su rivista | |
| 1-gen-2020 | Obesity and common pathways of cancer and cardiovascular disease | Formica, V; Morelli, C; Riondino, S; Renzi, N; Nitti, D; Di Daniele, N; Roselli, M; Tesauro, M | Articolo su rivista | |
| 1-nov-2024 | PD-L1 thresholds predict efficacy of immune checkpoint inhibition in first-line treatment of advanced gastroesophageal adenocarcinoma. A systematic review and meta-analysis of seven phase III randomized trials | Formica, V; Morelli, C; Fornaro, L; Riondino, S; Rofei, M; Fontana, E; Smyth, Ec; Roselli, M; Arkenau, H | Articolo su rivista | |
| 25-set-2023 | Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) | Morelli, C; Formica, V; Bossi, P; Rofei, M; Guerriero, S; Riondino, S; Argirò, R; Pucci, N; Cenci, T; Savino, L; Rinaldi, Cg; Garaci, F; Orlandi, A; D'Angelillo, Rm; Arkenau, H; Roselli, M | Articolo su rivista |